retatrutide and high blood pressure Future CKD & DM2 treatments: decreases UACR, BP increases GFR in Ph2 research study : r/FamilyMedicine Weight Loss Blog – Maryland

We searched PubMed (MEDLINE), EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL) and Web of Science from database inception to 31 October 2021 to identify eligible randomized controlled trials (RCTs)

By engaging with three hormone receptors, it enhances the weight loss effect, reducing hunger and promoting a sense of fullness

She has been prescribing GLP-1s for more than 10 years and authored a comprehensive guide to using them

GLP-1RA use was associated with a reduced risk of adverse outcomes in the full cohort (hazard ratio [HR] 0.79, 95% CI 0.66-0.96), and in UC (HR 0.73, 95% CI 0.54-0.98), though not significantly in CD (HR 0.86, 95% CI 0.66-1.08)

This means an expired dose delivers significantly less active drug, reducing your weight loss results and prolonging your treatment timeline